Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryoport (CYRX) Other Non Operating Income (2016 - 2026)

Cryoport has reported Other Non Operating Income over the past 17 years, most recently at -$2.4 million for Q1 2026.

  • Quarterly Other Non Operating Income fell 689.33% to -$2.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.4 million through Mar 2026, down 109.04% year-over-year, with the annual reading at $626000.0 for FY2025, 96.62% down from the prior year.
  • Other Non Operating Income was -$2.4 million for Q1 2026 at Cryoport, down from $3.3 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $17.3 million in Q3 2024 and troughed at -$5.0 million in Q1 2022.
  • The 5-year median for Other Non Operating Income is $525000.0 (2025), against an average of $1.3 million.
  • The largest YoY upside for Other Non Operating Income was 383.67% in 2022 against a maximum downside of 1064.16% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at $1.9 million in 2022, then skyrocketed by 206.15% to $5.7 million in 2023, then skyrocketed by 205.09% to $17.3 million in 2024, then plummeted by 80.72% to $3.3 million in 2025, then tumbled by 170.9% to -$2.4 million in 2026.
  • Per Business Quant, the three most recent readings for CYRX's Other Non Operating Income are -$2.4 million (Q1 2026), $3.3 million (Q4 2025), and $525000.0 (Q3 2025).